We write to you in reference to recent media reports claiming that Remedium Lifecare Limited has received an order worth ?8,500 crore from Eli Lilly and Company. The reports further suggest that this order marks a significant milestone for our company and the Indian pharmaceutical sector.We would like to categorically state that these reports are entirely speculative and unfounded. Remedium Lifecare Limited has not entered into any such agreement or received any orders from Eli Lilly and Company, as mentioned in the media.As a responsible corporate entity, we remain committed to providing accurate and timely information to the exchange and our stakeholders in accordance with the applicable regulations. Should there be any material developments or agreements that require disclosure, we will notify the exchange in due course.We kindly request BSE to take note of this clarification and advise investors and stakeholders to refrain from relying on unverified media reports.